The Efficacy and Safety of Topiramate in the Prevention of Pediatric Migraine: An Update Meta-Analysis

Volume: 8
Published: Feb 27, 2020
Abstract
Background: Migraine is the most common acute primary headache in children and adolescents. In 2014, topiramate became the first preventive drug for migraine approved by the Food and Drug Administration (FDA) in adolescents. This meta-analysis was aimed to evaluate the efficacy and safety of topiramate for the prevention of pediatric migraine. Methods: We searched the PubMed, EMBASE, Cochrane Library and Chinese National Knowledge Infrastructure...
Paper Details
Title
The Efficacy and Safety of Topiramate in the Prevention of Pediatric Migraine: An Update Meta-Analysis
Published Date
Feb 27, 2020
Volume
8
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.